๐Ÿฅ VAERS Vaccine Data Browser

๐Ÿ”’ Privacy & Data Disclaimer

About This Site

This is a public data browser for the Vaccine Adverse Event Reporting System (VAERS). By using this site, you acknowledge and agree to the following:

Data Source & Accuracy

  • Public Data: All data displayed comes from the publicly available VAERS database maintained by the CDC and FDA.
  • No Verification: VAERS accepts all reports without verifying medical accuracy. Reports do not prove causation between vaccines and adverse events.
  • Anyone Can Report: Healthcare providers, patients, family members, and anyone else can submit reports to VAERS.
  • Research Purpose: This data is for transparency, research, and monitoring vaccine safety signals only.

Your Privacy

  • No Personal Data Collection: This site does not collect, store, or track any personal information about visitors.
  • No Cookies: We do not use cookies except for remembering that you've seen this disclaimer (stored locally in your browser).
  • No Analytics: We do not use Google Analytics or any other tracking services.
  • Search Privacy: Your searches and filters are not logged or stored on our servers.
  • Public Data Only: The VAERS data shown here is already public and contains no personally identifiable information.

Medical Disclaimer

  • Not Medical Advice: This tool is for informational purposes only and does not provide medical advice.
  • Consult Healthcare Providers: Always consult qualified healthcare professionals for medical decisions.
  • No Liability: We are not responsible for decisions made based on this data.

Data Interpretation

  • The presence of a report does not mean the vaccine caused the adverse event.
  • Coincidental events are often reported (e.g., a heart attack that happened to occur after vaccination).
  • Serious adverse events must be reported by law, even if unrelated to the vaccine.
  • The database is useful for detecting safety signals that require further investigation.

๐Ÿ“– Help & Search Guide

Column Icons Legend

๐Ÿ’€ Death
๐Ÿฅ Hospitalized
๐Ÿš‘ Emergency Room
โ™ฟ Disability
โš ๏ธ Life Threatening

How to Search

๐Ÿ’ก Search Tips:
  • Select Year: Choose a specific year OR "All Years" to search across all data
  • All Years requires filters: When searching all years, you must select at least one filter (lot number, vaccine type, outcome, etc.) for performance
  • Lot number tracking: Use "All Years" + Lot Number to track lots across multiple years
  • Combine filters: Use multiple filters together to narrow results (e.g., Age + Vaccine Type + Death)
  • VAERS ID: Search for specific report by ID number
  • Age: Enter exact age (e.g., 25) or decimal (e.g., 0.5 for 6 months)
  • State: Enter 2-letter state code (e.g., CA, NY, TX)
  • Vaccine Type: Search partial names (e.g., "COVID19", "FLU", "HPV")
  • Manufacturer: Search by company (e.g., "PFIZER", "MODERNA")
  • Lot Number: Search specific vaccine lot (works great with "All Years")
  • Symptoms: Search for any symptom keyword (e.g., "fever", "rash")
  • Death/Hospitalized: Filter to only show cases with these outcomes

Understanding the Data

  • Reports are unverified: VAERS accepts all reports without medical verification
  • Not proof of causation: A report does not mean the vaccine caused the event
  • Anyone can report: Healthcare providers, patients, and family members can submit reports
  • Multiple vaccines: One report may list multiple vaccines given at the same time
  • Blank fields: Not all fields are required, so some data may be missing

Using the Table

  • Sort columns: Click column headers (ID, Age, Sex, Date, Died) to sort
  • Expand text: Click "More" to see full narrative or symptom text
  • Navigate pages: Use pagination controls at top and bottom of table
  • Export results: Click "๐Ÿ“ฅ Export CSV" to download filtered data (max 10,000 records)

๐Ÿ’ก Frequently Asked Questions (FAQ)

What is this site?

๐Ÿฅ VAERS Vaccine Data Browser is an independent, third-party data browser for publicly available VAERS (Vaccine Adverse Event Reporting System) data.

Important: This site is NOT affiliated with, endorsed by, or operated by the CDC, FDA, or any government agency. We are an independent service that makes public VAERS data easier to search and analyze.

What is VAERS?

VAERS (Vaccine Adverse Event Reporting System) is a national early warning system established in 1990 to detect possible safety problems with vaccines. It's co-managed by the CDC (Centers for Disease Control and Prevention) and FDA (Food and Drug Administration).

VAERS accepts and analyzes reports of adverse events (possible side effects) after a person has received a vaccination.

Official VAERS website: vaers.hhs.gov

Is this data HIPAA compliant?

Yes, absolutely. All VAERS data displayed here is:

  • Publicly available - Published by the CDC/FDA on their official website
  • De-identified - Contains no personally identifiable information (names, addresses, contact info removed)
  • Legally accessible - Available to researchers, media, and the general public under FOIA (Freedom of Information Act)
  • Not protected health information - Once de-identified and published by the government, it's no longer covered by HIPAA restrictions

This site displays the same public data available at vaers.hhs.gov/data.

Why does this site exist?

We believe in transparency and public access to health data. While the CDC/FDA provide VAERS data, their official site:

  • Is difficult to search and filter
  • Requires downloading large CSV files and technical knowledge
  • Is not user-friendly for the average person

This independent site makes the same publicly available data easier to search, filter, and understand for researchers, journalists, healthcare workers, and concerned citizens.

Where does the data come from?

All data is downloaded directly from the official CDC/FDA VAERS website at vaers.hhs.gov/data.

The data is:

  • Publicly released by the CDC/FDA every week
  • Available as downloadable CSV files
  • Imported into this site's database for easier searching
  • Displayed exactly as provided (no modifications or filtering)

This site does not collect, modify, or add to the official VAERS data.

My vaccine lot number matches one with deaths/serious events - should I be worried?

Important context:

  • VAERS reports do NOT prove causation - A report means an event occurred after vaccination, but doesn't mean the vaccine caused it
  • Anyone can report - Reports are not verified for medical accuracy before being published
  • Coincidences happen - When millions of people get vaccinated, some will experience unrelated medical events afterward
  • Large lot numbers - Popular vaccines may have hundreds of thousands of doses from one lot number
  • More vaccinations = more reports - Lots used widely will naturally have more reports

What to do:

  • Don't panic - VAERS data requires expert analysis to interpret
  • Talk to your doctor if you have concerns
  • Check official CDC/FDA safety communications for genuine safety signals
  • Remember: billions of vaccine doses have been safely administered

Can I trust VAERS data?

VAERS is valuable but has limitations:

Strengths:

  • โœ… Early warning system for potential safety signals
  • โœ… Open and transparent - publicly accessible
  • โœ… Accepts all reports regardless of likelihood of causation
  • โœ… Monitored by CDC/FDA experts who investigate concerning patterns

Limitations:

  • โš ๏ธ Reports are unverified - not investigated before publication
  • โš ๏ธ Cannot determine if vaccine caused the event
  • โš ๏ธ Underreporting - not all adverse events are reported
  • โš ๏ธ Overreporting - coincidental events may be reported
  • โš ๏ธ Incomplete data - not all fields are required

Bottom line: VAERS is an important tool for safety monitoring, but individual reports should not be used as proof that a vaccine caused harm.

What are "adverse events"?

An adverse event is any undesirable health occurrence that happens after vaccination, including:

  • Common reactions: Sore arm, mild fever, fatigue (usually expected)
  • Serious events: Hospitalization, disability, life-threatening illness, death
  • Coincidental events: Medical conditions that would have occurred anyway

Important: An adverse event doesn't mean the vaccine caused it - only that it occurred after vaccination. Many reported events are coincidental or unrelated.

Why are some lot numbers listed multiple times?

This is normal and expected! A person may receive multiple doses of the same vaccine from the same lot number:

  • COVID vaccines require 2-3 doses
  • HPV, Hepatitis B, and other vaccines have multi-dose schedules
  • Each dose is recorded as a separate entry

Example: Person receives Pfizer COVID dose 1 (lot ABC123) and dose 2 (lot ABC123) - lot ABC123 appears twice in their report.

How often is this data updated?

The CDC/FDA releases new VAERS data every Friday. This site is typically updated:

  • Weekly or bi-weekly for recent data
  • Check the available years to see what data is currently loaded
  • During updates, the site may be in maintenance mode temporarily

Where can I learn more?

โš ๏ธ DISCLAIMER: This data is from the Vaccine Adverse Event Reporting System (VAERS). Reports do not establish causation between vaccines and adverse events. Anyone can submit a report, and reports are not verified. This is raw data for transparency and research purposes only.
34,052
Total Reports (2025)
500
Deaths Reported
1,634
Hospitalizations
30
ER Visits
1,191
Disabilities
570
Life Threatening
๐Ÿ”„ Reset ๐Ÿ“ฅ Export CSV
ID Age Sex State Date โ–ผ Onset Days Vaccine Manufacturer Lot # Symptoms Narrative ๐Ÿ’€ ๐Ÿฅ ๐Ÿš‘ โ™ฟ โš ๏ธ
2826523 M FL 02/17/2025 VARZOS
 GLAXOSMITHKLINE BIOLOGICALS
 YZ9CY
Extra dose administered Extra dose administered
patient received an extra 3rd dose of Shingrix by accident back on February 8th 2025; This non-serio... patient received an extra 3rd dose of Shingrix by accident back on February 8th 2025; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of extra dose administered in a 64-year-old male patient who received Herpes zoster (Shingrix) (batch number YZ9CY) for prophylaxis. Previously administered products included Shingrix (received 1st dose on 28-FEB-2022 with batch number TM449) and Shingrix (received 2nd dose on 29-APR-2022 with batch number 445XD). On 08-FEB-2025, the patient received the 3rd dose of Shingrix. On 08-FEB-2025, an unknown time after receiving Shingrix, the patient experienced extra dose administered (Verbatim: patient received an extra 3rd dose of Shingrix by accident back on February 8th 2025). The outcome of the extra dose administered was unknown. Additional Information: GSK Receipt Date: 13-FEB-2025 The pharmacist mentioned that a patient received an extra 3rd dose of Shingrix by accident back on 8th February 2025 which led to extra dose administration. The patient received 2 prior Shingrix doses on 29th April 2022 and 28th February 2022. Expiration dates were unknown by reporter. More
2826524 U 02/17/2025 VARZOS
 GLAXOSMITHKLINE BIOLOGICALS
Inappropriate schedule of product administration Inappropriate schedule of product administration
Late 2nd dose; This non-serious case was reported by a other health professional via call center rep... Late 2nd dose; This non-serious case was reported by a other health professional via call center representative and described the occurrence of drug dose administration interval too long in a patient who received Herpes zoster (Shingrix) for prophylaxis. Previously administered products included Shingrix (received 1st dose on 30-MAY-2023). On 07-DEC-2024, the patient received the 2nd dose of Shingrix. On 07-DEC-2024, an unknown time after receiving Shingrix, the patient experienced drug dose administration interval too long (Verbatim: Late 2nd dose). The outcome of the drug dose administration interval too long was unknown. Additional Information: GSK Receipt Date: 13-FEB-2025 The health care professional reported that a patient that was came in for their second dose of shingrix. No further details were obtained from the chatter, only what is shown here in this report. The patient received 2nd dose of Shingrix, later than the recommended interval, which led to lengthening of vaccination schedule. More
2826525 U FL 02/17/2025 TDAP
 GLAXOSMITHKLINE BIOLOGICALS
 UNK
Product storage error Product storage error
the lowest temperature the vaccine reached was thirty-four point six degrees Fahrenheit.; This non-s... the lowest temperature the vaccine reached was thirty-four point six degrees Fahrenheit.; This non-serious case was reported by a nurse via call center representative and described the occurrence of incorrect storage of drug in a patient who received DTPa (Reduced antigen) (Boostrix) for prophylaxis. On an unknown date, the patient received Boostrix. On an unknown date, an unknown time after receiving Boostrix, the patient experienced incorrect storage of drug (Verbatim: the lowest temperature the vaccine reached was thirty-four point six degrees Fahrenheit.). The outcome of the incorrect storage of drug was unknown. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 13-FEB-2025 The reporter reported that Boostrix vaccine was administered to a patient and afterwards they realized the lowest storage temperature of this vaccine was thirty-five point four degrees Fahrenheit. Afterwards during the same call, Nurse Practitioner confirmed the lowest temperature the vaccine reached was thirty-four point six degrees Fahrenheit, which led to incorrect storage of drug. More
2826526 17 F CA 02/17/2025 MENB
 NOVARTIS VACCINES AND DIAGNOSTICS
 FH443
Product storage error Product storage error
Patient administered Bexsero/Improper Storage Error; This non-serious case was reported by a other h... Patient administered Bexsero/Improper Storage Error; This non-serious case was reported by a other health professional via call center representative and described the occurrence of incorrect storage of drug in a 17-year-old female patient who received Men B NVS (Bexsero) (batch number FH443, expiry date 30-SEP-2027) for prophylaxis. On 21-JAN-2025, the patient received Bexsero. On an unknown date, an unknown time after receiving Bexsero, the patient experienced incorrect storage of drug (Verbatim: Patient administered Bexsero/Improper Storage Error). The outcome of the incorrect storage of drug was unknown. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK receipt date: 13-FEB-2025 The reporter requested a stability data on Bexsero, Havrix, Kinrix, Infanrix, Engerix-B, Rotarix (liq) stored at 1st on 07th January 2025 at 46,7 Fahrenheit in to 30 mins and 2nd on 21st January 2025 at 49.4 Fahrenheit in to 2hrs 30mins. The reporter mentioned that the patient administered Bexsero vaccine which led to, incorrect storage of drug. More
2826527 30 F IL 02/17/2025 TDAP
 GLAXOSMITHKLINE BIOLOGICALS
 M77CC
Erythema, Exposure during pregnancy, Swelling Erythema, Exposure during pregnancy, Swelling
pregnant women recived Boostrix vaccine; mentioned that they began to present swelling that exceeded... pregnant women recived Boostrix vaccine; mentioned that they began to present swelling that exceeded the 50 mm; mentioned that they began to present redness that exceeded the 50 mm; This non-serious prospective pregnancy case was reported by a pharmacist via call center representative and described the occurrence of erythema in a 30-year-old female patient who received DTPa (Reduced antigen) (Boostrix) (batch number M77CC, expiry date 19-MAR-2027) for prophylaxis. On 11-FEB-2025, the patient received Boostrix. On 11-FEB-2025, less than a day after receiving Boostrix, the patient experienced erythema (Verbatim: mentioned that they began to present redness that exceeded the 50 mm). On 12-FEB-2025, the patient experienced swelling (Verbatim: mentioned that they began to present swelling that exceeded the 50 mm). On an unknown date, the patient experienced vaccine exposure during pregnancy (Verbatim: pregnant women recived Boostrix vaccine). The outcome of the erythema, swelling and vaccine exposure during pregnancy were unknown. It was unknown if the reporter considered the erythema and swelling to be related to Boostrix and Boostrix Pre-Filled Syringe Device. It was unknown if the company considered the erythema and swelling to be related to Boostrix and Boostrix Pre-Filled Syringe Device. Pregnancy exposure: Gestation time at first exposure (Boostrix): 36 Weeks Pregnancy Exposure (Boostrix): To mother in third trimester Estimated Delivery/Due date: 27-FEB-2025 Pregnancy Outcome: Pregnancy was ongoing This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK receipt date: 13-FEB-2025 The pharmacist contacted GlaxoSmithKline to request data on how long grade 3 swelling and redness lasted before they resolved, mentioning that a patient 36 weeks pregnant received a dose of Boostrix. However, they mentioned that they began to present swelling and redness that "exceeded the 50 mm" described in the prescribing information. They wished to know if they had data on how long it took for the symptoms to resolve. The Vaccine Administration Facility is the same as Primary Reporter. More
2826528 43 M 02/17/2025 COVID19
COVID19
 MODERNA
MODERNA
 014C21A
014C21A
Asthenia, Burning sensation, Disorientation, Fatigue, Hallucination; Muscle atro... Asthenia, Burning sensation, Disorientation, Fatigue, Hallucination; Muscle atrophy, Muscle twitching, Palpitations, Vision blurred More
hallucination; fatigued; disoriented; heart palpitations; weakness; burning in feet; muscle twitchin... hallucination; fatigued; disoriented; heart palpitations; weakness; burning in feet; muscle twitching; blurry vision; My muscles and my body keep melting away; This spontaneous case was reported by a patient and describes the occurrence of HALLUCINATION (hallucination) in a 43-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 014C21A and 054C21A) for COVID-19 prophylaxis. The occurrence of additional non-serious events is detailed below. No Medical History information was reported. On 03-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular use) 1 dosage form. On 04-Jun-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular use) dosage was changed to 1 dosage form. On an unknown date, the patient experienced HALLUCINATION (hallucination) (seriousness criterion medically significant), FATIGUE (fatigued), DISORIENTATION (disoriented), PALPITATIONS (heart palpitations), ASTHENIA (weakness), BURNING SENSATION (burning in feet), MUSCLE TWITCHING (muscle twitching), VISION BLURRED (blurry vision) and MUSCLE ATROPHY (My muscles and my body keep melting away). At the time of the report, HALLUCINATION (hallucination), FATIGUE (fatigued), DISORIENTATION (disoriented), PALPITATIONS (heart palpitations), ASTHENIA (weakness), BURNING SENSATION (burning in feet), MUSCLE TWITCHING (muscle twitching), VISION BLURRED (blurry vision) and MUSCLE ATROPHY (My muscles and my body keep melting away) outcome was unknown. Concomitant product use was not provided by the reporter. He was fatigued when he got his shot. The caller narrated that after he received the vaccine, he experienced disorientation, heart palpitations, hallucinations, weakness, burning in the feet, muscle twitching, blurry vision. The caller also added that his muscles and body keep melting away. The caller further narrates that after the second dose, everything goes downhill. The patient had been fighting for his life every second of the day, every second of the day from then, every second, and was used to being strong and healthy, but could barely walk to the bathroom. It was bad. This was unfair. The patient was a big strong man, going to the gym 5 days a week and now, he was an individual that could barely walk to the restroom. It was unknown if the patient experienced any additional symptoms/events. Reporter causality was not reported. Treatment information was not provided. This case was linked to US-MODERNATX, INC.-MOD-2025-782272 (E2B Linked Report).; Reporter's Comments: Company comment: The benefit-risk relationship of product is not affected by this report.; Sender's Comments: US-MODERNATX, INC.-MOD-2025-782272:Invalid case for multiple patients More
2826529 81 M 02/17/2025 COVID19
 MODERNA
Pain in extremity Pain in extremity
it hurt a little bit in his arm; This spontaneous case was reported by a patient and describes the o... it hurt a little bit in his arm; This spontaneous case was reported by a patient and describes the occurrence of PAIN IN EXTREMITY (it hurt a little bit in his arm) in an 81-year-old male patient who received mRNA-1273.712 (SPIKEVAX 2024-2025 PFS) for COVID-19 prophylaxis. Previously administered products included for Product used for unknown indication: Shingrix Shingles vaccine (dose 1) in 2021 and Shingrix Shingles vaccine (dose 2). Past adverse reactions to the above products included No adverse effect with Shingrix Shingles vaccine; and Vaccination adverse reaction with Shingrix Shingles vaccine. On 27-Aug-2024, the patient received fifth dose of mRNA-1273.712 (SPIKEVAX 2024-2025 PFS) (Intramuscular use) .5 milliliter. On an unknown date, the patient experienced PAIN IN EXTREMITY (it hurt a little bit in his arm). At the time of the report, PAIN IN EXTREMITY (it hurt a little bit in his arm) had resolved. No concomitant medication was reported. The reporter denies experiencing any type of reaction but mentioned it hurt a little bit in his arm. The reporter states he had a very bad reaction after receiving the first dose of the Shingrix Shingles vaccine in 2021, which really knocked his socks off and lasted one day. There was no reaction to the second dose of the shingles vaccine. No other details were provided. Reporter causality was not reported. No treatment medication was reported. This case was linked to US-MODERNATX, INC.-MOD-2025-782370, US-MODERNATX, INC.-MOD-2025-782389 (E2B Linked Report).; Sender's Comments: US-MODERNATX, INC.-MOD-2025-782370:Wife case (Spikevax (2024-2025) US-MODERNATX, INC.-MOD-2025-782389:Invalid case for some people More
2826530 26 M 02/17/2025 COVID19
 MODERNA
Chills, Fatigue, Headache, Pain Chills, Fatigue, Headache, Pain
soreness/aches; chills; headache; fatigue; This spontaneous case was reported by a consumer and desc... soreness/aches; chills; headache; fatigue; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (soreness/aches), CHILLS (chills), HEADACHE (headache) and FATIGUE (fatigue) in a 26-year-old male patient who received mRNA-1273.712 (SPIKEVAX 2024-2025 PFS) for COVID-19 prophylaxis. Concomitant products included Sertraline hydrochloride (Sertraline) and Influenza vaccine (Fluzone) for an unknown indication. On 12-Feb-2025, the patient received dose of mRNA-1273.712 (SPIKEVAX 2024-2025 PFS) (Intramuscular use) 1 dosage form. On 13-Feb-2025, the patient experienced PAIN (soreness/aches), CHILLS (chills), HEADACHE (headache) and FATIGUE (fatigue). At the time of the report, PAIN (soreness/aches), CHILLS (chills), HEADACHE (headache) and FATIGUE (fatigue) was resolving. For mRNA-1273.712 (SPIKEVAX 2024-2025 PFS) (Intramuscular use), the reporter did not provide any causality assessments. The patient had no past medical history, no concomitant disease or risk factor. There were no lab data/results available. No treatment information was reported. Reporter did not allow further contact More
2826531 52 F AZ 02/17/2025 COVID19
 PFIZER\BIONTECH
 FC3183
Computerised tomogram, Magnetic resonance imaging, Renal cell carcinoma Computerised tomogram, Magnetic resonance imaging, Renal cell carcinoma
renal cell carcinoma; This is a spontaneous report received from a Consumer or other non HCP. A 54-... renal cell carcinoma; This is a spontaneous report received from a Consumer or other non HCP. A 54-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 10Sep2021 as dose 3 (booster), single (Lot number: FC3183) at the age of 52 years for covid-19 immunisation. The patient's relevant medical history included: "Lupus" (unspecified if ongoing); "Hypertension" (unspecified if ongoing); "mitral valve regurgitation" (unspecified if ongoing). Concomitant medication(s) included: LISINOPRIL; ESTRADIOL; OXYBUTYNIN; GABAPENTIN; HYDROXYZINE; ROSUVASTATIN. Past drug history included: Keflex, reaction(s): "known allergies: Keflex", notes: known allergies: Keflex. Vaccination history included: BNT162b2 (Dose 2, single, Lot no EL9625, facility type vaccine: Workplace clinic), administration date: 25Jan2021, when the patient was 51-year-old, for COVID-19 immunization; BNT162b2 (Dose 1, single, Lot no EL3246, facility type vaccine: Workplace clinic), administration date: 04Jan2021, when the patient was 51-year-old, for COVID-19 immunization. The following information was reported: RENAL CELL CARCINOMA (caused and prolonged hospitalization, medically significant) with onset 01Jun2023, outcome "recovering". The patient was hospitalized and prolonged hospitalization for renal cell carcinoma (hospitalization duration: 3 day(s)). The patient underwent the following laboratory tests and procedures: Computerised tomogram: unknown results; Magnetic resonance imaging: unknown results. Therapeutic measures were taken as a result of renal cell carcinoma. Clinical course: Patient ended up with renal cell carcinoma and had a partial nephrectomy Sep2023. She had no history of cancer. More
โœ“
2826534 U AZ 02/17/2025 COVID19
COVID19
COVID19
 PFIZER\BIONTECH
PFIZER\BIONTECH
PFIZER\BIONTECH


Biopsy, Computerised tomogram, Cough, Dyspnoea, Echocardiogram; Endoscopy, Fatig... Biopsy, Computerised tomogram, Cough, Dyspnoea, Echocardiogram; Endoscopy, Fatigue, Immunology test, Investigation, Pain; Urine analysis, X-ray More
chronic pain; fatigue; breathing difficulties; chronic cough; The initial case was missing the follo... chronic pain; fatigue; breathing difficulties; chronic cough; The initial case was missing the following minimum criteria: Unspecified product. Upon receipt of follow-up information on 10Feb2025, this case now contains all required information to be considered valid. This is a spontaneous report received from a Consumer or other non HCP, Program ID. An adult patient received BNT162b2 (BNT162B2), on 12Aug2021 as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: BNT162b2 (DOSE 1), administration date: 21Jul2021, for COVID-19 immunization. The following information was reported: COUGH (medically significant) with onset Jun2022, outcome "unknown", described as "chronic cough"; PAIN (medically significant), outcome "unknown", described as "chronic pain"; FATIGUE (medically significant), outcome "unknown"; DYSPNOEA (medically significant), outcome "unknown", described as "breathing difficulties". The events "chronic cough", "chronic pain", "fatigue" and "breathing difficulties" required physician office visit. The patient underwent the following laboratory tests and procedures: Complement fixation tests: Unknown result; Immunology test: Unknown result; Unknown result; X-ray: Unknown result; Computerised tomogram: Unknown result; Biopsy: Unknown result; Urine analysis: Unknown result; Endoscopy: Unknown result; Echocardiogram: Unknown result. Clinical course: It was reported that the patient was chronically ill as a direct result of taking the Pfizer Covid-19 vaccine. On 21July2021, patient got the first Pfizer vaccination shot, followed by a second on 12Aug2021. Approximately eleven months later, in Jun2022, patient developed a chronic cough. The cough was something patient had never experienced previously as reported, and it has intensified to the point that it has brought other debilitating conditions, such as chronic pain, fatigue and breathing difficulties. Patient was reaching out for help. It was reported that patient have seen more than a dozen different physicians, and specialists, including but not limited to; Pulmonoligists, Cardiologists, Otolaryngologists, Gastroenterologists, Psychiatrists, Physical Therapists, Pain Management Doctors and others. Nobody was able to explain to me why his/her health has deteriorated as such, and the only conclusive evidence and obvious answer is that the Pfizer vaccine caused this condition. Additionally, patient have had more tests than can count, including: Complement fixation tests, enzyme immuneassay tests, latex agglutination tests, multiple x-rays and ct-scans, tissue biopsies, urinalysis's, endoscopies, cardiovascular echocardiograms. These are just some of the painstakingly and very aggravating time consuming tests patient have had to endure over the past 30+ months. To be clear, never before, he/she had or been seen anything like this, nor had previously been diagnosed with this chronic cough. All of the physicians are dumbfounded and perplexed as to this chronic condition and one can only deduce from the evidence at hand, and determine by process of elimination, that the underlying cause is the Pfizer vaccine. Patient reiterated that he/she did not have this cough and serious illness, prior to receiving the vaccines. The cough is sporadic and when it comes on, it is very hard to decipher how long it will last. Sometimes it is only a few minutes, other times it can last so long, that patient can literally blackout. Patient pointed out that he/she did not get any other shots or vaccines of any kind, from the time patient got this vaccines. The information on the batch/lot number for BNT162b2 will be requested and submitted if and when received. More
2826535 U NJ 02/17/2025 COVID19
 PFIZER\BIONTECH
COVID-19, Vaccination failure COVID-19, Vaccination failure
original covid / rebound covid; original covid / rebound covid; This is a spontaneous report receive... original covid / rebound covid; original covid / rebound covid; This is a spontaneous report received from a Consumer or other non HCP. A patient (age and gender not provided) received BNT162b2 (BNT162B2 NOS), in Aug2024 as dose 1, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "Type 2 Diabetes", start date: May2023 (unspecified if ongoing). The patient's concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (primary immunization series complete; unknown manufacturer), for COVID-19 immunization; Covid-19 vaccine (dose number unknown (booster); unknown manufacturer), for COVID-19 immunization. The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "original covid / rebound covid". Therapeutic measures were taken as a result of vaccination failure, covid-19. Clinical course: Regularly get covid boosters when available. Last was Aug2024 before travel. Original covid symptoms included nasal congestion, some throat fever, aches, chills, minor cough, fatigue. The patient started treatment with oral Paxlovid from 23Jan2025 to 28Jan2025. Rebound symptoms included fatigue nasal congestion, shorter time sore throat, strong cough- no fever, aches or chills on never had any chest /lung issue. The patient is not allergic to any previous vaccination, medications, food or other products. The information on the batch/lot number for BNT162b2 will be requested and submitted if and when received. More
2826536 8 F SC 02/17/2025 UNK
 UNKNOWN MANUFACTURER
 No batch number
Lip swelling Lip swelling
The patient experienced lip swelling; This spontaneous case initially received on 05-Feb-2025, was r... The patient experienced lip swelling; This spontaneous case initially received on 05-Feb-2025, was reported by a health professional and concerns a child female patient. Concomitant medication: unknown. Medical history: no previous allergies to vaccines, medications or food. Administration of company suspect drug: On 04-Oct-2024, the patient received Afluria (TIV) for prevention of disease caused by influenza A subtype viruses and type B virus contained in the vaccine., dose 0.5 ml, route of administration: not reported. Dose regimen, route of administration: not reported, Lot number not reported and requested upon follow-up. No additional suspect drugs. Adverse reactions/events and outcomes: On 04-Oct-2025, the patient experienced the patient experienced Lip swelling (outcome: Recovered / Resolved). A patient received Afluria prefilled syringe and experienced lip swelling right after vaccination and least for a week. No breathing issue was reported. Afluria (TIV) action taken: Not Applicable Reporter๏ฟฝs assessment: The reporter considered Lip swelling as non-serious and causality not provided.; Reporter's Comments: Lip swelling is related More
2826537 80 F FL 02/17/2025 VARZOS
 GLAXOSMITHKLINE BIOLOGICALS
 74NC9
Chills Chills
Systemic: Chills-Severe Systemic: Chills-Severe
2826538 57 F CA 02/17/2025 VARZOS
 GLAXOSMITHKLINE BIOLOGICALS
 354m3
Injection site erythema, Injection site pain, Injection site swelling Injection site erythema, Injection site pain, Injection site swelling
Site: Pain at Injection Site-Medium, Site: Redness at Injection Site-Medium, Site: Swelling at Injec... Site: Pain at Injection Site-Medium, Site: Redness at Injection Site-Medium, Site: Swelling at Injection Site-Medium, Additional Details: spoke to patient on the phone and in person, she did not request any follow up and seemed satisfied.she picked up a medication for her reaction she had to the vaccince after vising an urgent care.she started having reaction (redness/pain and inflamation) 2 or 3 days after vaccince administaration date. No complains from patient.I want to report her reaction she had to the vaccince.thanks More
2826539 69 F NY 02/17/2025 PNC20
 PFIZER\WYETH
 LJ5284
Injection site erythema, Injection site swelling, Pain Injection site erythema, Injection site swelling, Pain
Site: Redness at Injection Site-Medium, Site: Swelling at Injection Site-Medium, Systemic: Body Ache... Site: Redness at Injection Site-Medium, Site: Swelling at Injection Site-Medium, Systemic: Body Aches Generalized-Medium, Additional Details: patient came in on sunday 2/8/2025 with rx for keflex and medrol dose pack. local skin reaction with redness around injection site, Other Vaccines: VaccineTypeBrand: prevnar 20; Manufacturer: wyeth pfizer; LotNumber: lj5284; Route: im; BodySite: left; Dose: 1; VaxDate: 02/04/2025 More
2826540 31 F MA 02/17/2025 TDAP
 GLAXOSMITHKLINE BIOLOGICALS
 010035816084
Neck pain Neck pain
Systemic: neck pain that started 2 hrs after vaccine given, patient took pain killers and iced with ... Systemic: neck pain that started 2 hrs after vaccine given, patient took pain killers and iced with no positive outcome, still painful-Severe More
2826541 60 F CA 02/17/2025 PNC20
PNC20
 PFIZER\WYETH
PFIZER\WYETH
 LK6651
LK6651
Headache, Hypoaesthesia, Immediate post-injection reaction, Injection site pain,... Headache, Hypoaesthesia, Immediate post-injection reaction, Injection site pain, Injection site swelling; Pain, Paraesthesia More
Site: Pain at Injection Site-Severe, Site: Swelling at Injection Site-Medium, Systemic: Body Aches G... Site: Pain at Injection Site-Severe, Site: Swelling at Injection Site-Medium, Systemic: Body Aches Generalized-Medium, Systemic: Headache-Mild, Systemic: Numbness (specify: facial area, extremities)-Medium, Systemic: Tingling (specify: facial area, extemities)-Medium, Additional Details: Gave first vax Flucelvax in L arm. Then gave Prevnar 20 1" below. Pt complained immediate pain, upon withdrawal said still felt like needle was in. Monitored 25min. Did not resolve. But she could walk and drive. Called pt several hrs later, still in pain but slightly better. Will follow up in 24-48 hours again. It appeared more of a neurological issue than vaccine per se. Will follow up for resolution., Other Vaccines: VaccineTypeBrand: Flucelvax; Manufacturer: Sequiris; LotNumber: 946619; Route: IM; BodySite: L arm; Dose: 1; VaxDate: 02/09/2025 More
2826542 76 M FL 02/17/2025 COVID19
 PFIZER\BIONTECH
 GH9697
Tremor Tremor
Systemic: left hand shaking. Started 1 year ago-Medium Systemic: left hand shaking. Started 1 year ago-Medium
2826543 24 F CO 02/17/2025 COVID19
 NOVAVAX
 6024mf023a
Dizziness, Nausea Dizziness, Nausea
Systemic: Dizziness / Lightheadness-Mild, Systemic: Nausea-Mild, Additional Details: patient also no... Systemic: Dizziness / Lightheadness-Mild, Systemic: Nausea-Mild, Additional Details: patient also noted she started wellbutrin recently and thinks this reaction could be due to the new medication. dizzy more easily, Other Vaccines: VaccineTypeBrand: flucelvax; Manufacturer: seqirus; LotNumber: 946619; Route: im; BodySite: left arm; Dose: ; VaxDate: UNKNOWN More
2826544 18 F GA 02/17/2025 MMR
MMR
MMR
 MERCK & CO. INC.
MERCK & CO. INC.
MERCK & CO. INC.
 x022986
x022986
x022986
Dizziness, Fatigue, Flushing, Hyperhidrosis, Hypotension; Injection site erythem... Dizziness, Fatigue, Flushing, Hyperhidrosis, Hypotension; Injection site erythema, Lethargy, Seizure, Syncope, Tremor; Unresponsive to stimuli More
Site: Redness at Injection Site-Mild, Systemic: Dizziness / Lightheadness-Mild, Systemic: Exhaustion... Site: Redness at Injection Site-Mild, Systemic: Dizziness / Lightheadness-Mild, Systemic: Exhaustion / Lethargy-Mild, Systemic: Fainting / Unresponsive-Mild, Systemic: Flushed / Sweating-Mild, Systemic: Hypotension-Mild, Systemic: Seizure-Mild, Systemic: Shakiness-Mild More
2826545 39 F CA 02/17/2025 TDAP
 GLAXOSMITHKLINE BIOLOGICALS
 xn575
Hypoaesthesia Hypoaesthesia
Systemic: Numbness (specify: facial area, extremities)-Medium, Additional Details: patient experienc... Systemic: Numbness (specify: facial area, extremities)-Medium, Additional Details: patient experiencing numbness in feet, recommended to also follow up with physician More
2826546 25 F CA 02/17/2025 HEP
 DYNAVAX TECHNOLOGIES CORPORATION
 945657
Injection site pain Injection site pain
Site: Pain at Injection Site-Medium, Additional Details: PATIENT STILL HAVING ARM PAIN IN DELTIOD 8 ... Site: Pain at Injection Site-Medium, Additional Details: PATIENT STILL HAVING ARM PAIN IN DELTIOD 8 DAYS AFTER SHOT, Other Vaccines: VaccineTypeBrand: IPOL; Manufacturer: ; LotNumber: X1C891M; Route: IM; BodySite: LEFT ARM; Dose: 1; VaxDate: 02/03/2025, VaccineTypeBrand: BOOSTRIX; Manufacturer: ; LotNumber: XN575; Route: IM; BodySite: LEFT ARM; Dose: 1; VaxDate: 02/03/2025, VaccineTypeBrand: FLUCELVAX; Manufacturer: ; LotNumber: 946619; Route: IM; BodySite: LEFT ARM; Dose: 1; VaxDate: 02/03/2025 More
2826548 58 M MO 02/17/2025 VARZOS
 GLAXOSMITHKLINE BIOLOGICALS
 24m7e
Headache, Hyperhidrosis Headache, Hyperhidrosis
Systemic: Headache-Severe, Additional Details: patient mentioned he has some headaches and is sweati... Systemic: Headache-Severe, Additional Details: patient mentioned he has some headaches and is sweating More
2826550 70 M NY 02/17/2025 RSV
RSV
RSV
RSV
 GLAXOSMITHKLINE BIOLOGICALS
GLAXOSMITHKLINE BIOLOGICALS
GLAXOSMITHKLINE BIOLOGICALS
GLAXOSMITHKLINE BIOLOGICALS
 ln4p2
ln4p2
LN4P2
LN4P2
Injection site pain, Mobility decreased; Injected limb mobility decreased, Injec... Injection site pain, Mobility decreased; Injected limb mobility decreased, Injection site pain, Pain, Sleep disorder, X-ray limb; Injection site pain, Mobility decreased; Injected limb mobility decreased, Injection site pain, Pain, Sleep disorder, X-ray limb More
Site: Pain at Injection Site-Severe, Additional Details: PT came in a week or so after said his arm ... Site: Pain at Injection Site-Severe, Additional Details: PT came in a week or so after said his arm hurt really bad and couldnt lit it above his head. he wnt to the doctors and they confirmed it was from the shot. PT has had vaccines in the past with no issues. Its been a month and pt is doing exercise per md. More
2826551 58 F CA 02/17/2025 PNC21
 MERCK & CO. INC.
 y013009
Rash Rash
Systemic: Allergic: Rash (specify: facial area, extremeties)-Mild, Additional Details: rash on neck ... Systemic: Allergic: Rash (specify: facial area, extremeties)-Mild, Additional Details: rash on neck occurred, Other Vaccines: VaccineTypeBrand: pfizer covid; Manufacturer: pfizer; LotNumber: lm7786; Route: im; BodySite: left arm; Dose: ; VaxDate: UNKNOWN More
2826552 0.5 M FL 02/17/2025 DTAPHEPBIP
DTAPHEPBIP
PNC20
PNC20
 GLAXOSMITHKLINE BIOLOGICALS
GLAXOSMITHKLINE BIOLOGICALS
PFIZER\WYETH
PFIZER\WYETH



Crying, Fatigue, Influenza A virus test negative, Influenza B virus test negativ... Crying, Fatigue, Influenza A virus test negative, Influenza B virus test negative, Pyrexia; Rash, Screaming, Sleep disorder; Crying, Fatigue, Influenza A virus test negative, Influenza B virus test negative, Pyrexia; Rash, Screaming, Sleep disorder More
Several hours after vaccination, patient developed fatigue. Fever of 103+ degrees Fahrenheit develo... Several hours after vaccination, patient developed fatigue. Fever of 103+ degrees Fahrenheit developed by midnight (approx 9 hours after vaccination). 103 fever continued for 72 hours. Patient experienced severe fatigue, only waking for brief times (total 3-5 hours per day). Patient developed rash over entire body consisting of small spots day following vaccine that peaked on day 4 after vaccination. Patient began inconsolable screaming during awake times - screaming began day after vaccines and peaked on day 4. Beginning day 3, patient would not sleep due to inconsolable screaming. Pediatrician lines and urgent care advised "normal." More
2826553 40 F GA 02/17/2025 TDAP
TDAP
TDAP
TDAP
TDAP
TDAP
TDAP
TDAP
 GLAXOSMITHKLINE BIOLOGICALS
GLAXOSMITHKLINE BIOLOGICALS
GLAXOSMITHKLINE BIOLOGICALS
GLAXOSMITHKLINE BIOLOGICALS
GLAXOSMITHKLINE BIOLOGICALS
GLAXOSMITHKLINE BIOLOGICALS
GLAXOSMITHKLINE BIOLOGICALS
GLAXOSMITHKLINE BIOLOGICALS
 XN575
XN575
XN575
XN575
XN575
XN575
XN575
XN575
Blindness, Menstruation irregular, Pain in extremity, Visual impairment; Bell�... Blindness, Menstruation irregular, Pain in extremity, Visual impairment; Bell's palsy, Blindness unilateral, Cellulitis, Epistaxis, Injected limb mobility decreased; Pain, Pain in extremity, Peripheral swelling, Tenderness, Vaginal haemorrhage; Vision blurred; Blindness, Menstruation irregular, Pain in extremity, Visual impairment; Bell's palsy, Blindness unilateral, Cellulitis, Epistaxis, Injected limb mobility decreased; Pain, Pain in extremity, Peripheral swelling, Tenderness, Vaginal haemorrhage; Vision blurred More
On 2/14/2025, patient came in to get Boostrix vaccine. Later that evening, after 10pm, patient notic... On 2/14/2025, patient came in to get Boostrix vaccine. Later that evening, after 10pm, patient noticed spotting and loss of vision in her right eye. Patient states that her menstrual cycle started a week earlier and vision has not returned to her right eye. Patient states that she is trying to get an appointment with her doctor. Patient also reports still having a sore arm. More
2826554 33 F GA 02/17/2025 TD
TD
TD
 SANOFI PASTEUR
SANOFI PASTEUR
SANOFI PASTEUR
 U8492AA
U8492AA
U8492AA
Dysarthria, Erythema, Injected limb mobility decreased, Pain, Pain in extremity;... Dysarthria, Erythema, Injected limb mobility decreased, Pain, Pain in extremity; Panic reaction, Peripheral swelling, Pharyngeal swelling, Pyrexia, Swelling; Urticaria More
On February 13, 2025, the donor called the center and stated that she was having a severe reaction t... On February 13, 2025, the donor called the center and stated that she was having a severe reaction to her shot from the night prior. During this call, it was noted that donor's speech was slurred, and she sounded panicked. Donor stated that her left arm began hurting and had restricted range-of motion around 2230 on 02/12/25. Donor stated her symptoms kept progressing all night and into the following day on 02/13/25. Donor stated that her throat and neck was swollen, limited range of motion in her left arm, her face is red, fever, full body hives, her left leg is also swollen and sore, and she stated that her whole body was hurting. When donor was asked to rate her pain on a scale of 1 10 (with 10 being the worst pain), donor stated her pain is a 10/10. Donor stated she was on her way to the emergency room at a hospital. More
2826555 66 F NC 02/17/2025 VARZOS
VARZOS
 GLAXOSMITHKLINE BIOLOGICALS
GLAXOSMITHKLINE BIOLOGICALS

Chills, Headache, Injection site erythema, Pain, Rash erythematous; Rash pruriti... Chills, Headache, Injection site erythema, Pain, Rash erythematous; Rash pruritic, Urticaria More
I received the vaccine on Wednesday and on Sunday started noticing small red bumps on the torso and ... I received the vaccine on Wednesday and on Sunday started noticing small red bumps on the torso and back. They became itchy and turned into full blown hives by that night. It's Monday and they have become larger and more widespread. I also experienced headaches, chills and body aches but these are normal side effects. The injection site remained red and very sore 5 days in which is not typical. Can't tell duration of hives as I am in the middle of it. More
2826556 73 M FL 02/17/2025 PNC21
PNC21
 MERCK & CO. INC.
MERCK & CO. INC.
 Y013009
Y013009
Asthenia, Feeding disorder, Headache, Injection site pain, Pain; Pyrexia, Vomiti... Asthenia, Feeding disorder, Headache, Injection site pain, Pain; Pyrexia, Vomiting More
Severe weakness, headache, body ache, fever, vomiting, unable to eat, pain on injection site Severe weakness, headache, body ache, fever, vomiting, unable to eat, pain on injection site
2826557 1.25 M IL 02/17/2025 DTAP
HIBV
 GLAXOSMITHKLINE BIOLOGICALS
GLAXOSMITHKLINE BIOLOGICALS
 47Y5M
3PY4Y
Injection site urticaria; Injection site urticaria Injection site urticaria; Injection site urticaria
patient had hives on right thigh. lasted at least 24 hours - better the next day but not gone. was... patient had hives on right thigh. lasted at least 24 hours - better the next day but not gone. was given bendaryl OTC. totally gone after 48 hours. More
2826558 63 F FL 02/17/2025 TDAP
VARZOS
 GLAXOSMITHKLINE BIOLOGICALS
GLAXOSMITHKLINE BIOLOGICALS
 3zh27
n77j2
Rash; Rash Rash; Rash
Shingles like rash, advised patient to follow up with physician Shingles like rash, advised patient to follow up with physician
2826559 72 F NJ 02/17/2025 VARZOS
 GLAXOSMITHKLINE BIOLOGICALS
 X5T42
Injection site rash, Injection site swelling, Injection site warmth Injection site rash, Injection site swelling, Injection site warmth
Patient was vaccinated with Shingrix on 1/27/2025 at 1pm and the next day noticed a raised, hot rash... Patient was vaccinated with Shingrix on 1/27/2025 at 1pm and the next day noticed a raised, hot rash spot at the injection site. She reported to the pharmacy on 2/17/2025 that the site is better but still ho0t to the touch. She stated that the spot is warm but does not itch or hurt. More
2826560 0.08 F SC 02/17/2025 RSV
 PFIZER\WYETH
 HF5017
No adverse event, Product administered to patient of inappropriate age, Wrong pr... No adverse event, Product administered to patient of inappropriate age, Wrong product administered More
The nurse administered on 10/28/24 ABRYSVO RSV vaccine instead of the Beyfortus which is the one ord... The nurse administered on 10/28/24 ABRYSVO RSV vaccine instead of the Beyfortus which is the one ordered and the proper vaccine for this patient. No untoward side effect or reaction noted. Discussed with the mother. Baby will get the Beyfortus on Monday, 11/04/2024 as per guideline from CDC recommended. More
2826561 59 F MN 02/17/2025 HEP
 DYNAVAX TECHNOLOGIES CORPORATION
Arthralgia, Injection site bruising, Injection site discomfort Arthralgia, Injection site bruising, Injection site discomfort
discomfort at injection site after injection. Then several days later occasional pain at shoulder j... discomfort at injection site after injection. Then several days later occasional pain at shoulder joint, bruise at injection site. Today, shoulder joint pain continues along with discomfort at injection site. Should joint pain increases with activity. More
2826562 54 F VA 02/17/2025 VARZOS
 GLAXOSMITHKLINE BIOLOGICALS
 7ZM55
Injection site rash, Rash macular, Rash pruritic Injection site rash, Rash macular, Rash pruritic
6 days after receiving vaccine, patient developed macular rash on left deltoid area where Shingrix v... 6 days after receiving vaccine, patient developed macular rash on left deltoid area where Shingrix vaccine was placed. The rash caused itching. Patient prescribed triamcinolone 0.025% ointment to apply daily for 14 days over site of rash starting on 2/16/2025. More
2826563 11 F MA 02/17/2025 COVID19
FLU3
 PFIZER\BIONTECH
GLAXOSMITHKLINE BIOLOGICALS
 lm2045
n7cx5
Dizziness, Syncope; Dizziness, Syncope Dizziness, Syncope; Dizziness, Syncope
patient experienced vasovagal syncope after receiving the vaccinations upon standing. Patient was mo... patient experienced vasovagal syncope after receiving the vaccinations upon standing. Patient was monitored in the pharmacy for 20-25 mins. Patient experienced lightheadedness and fainting spells. Patient was told to lay flat with feet elevated, given water and offer a cold compress for their head. Patient was monitored by pharmacy staff and parents. Parent refused emergency services. Patient was alert and back to normal before departure. Patient advised to follow up with primary care and seek emergency services if condition worsens. More
2826564 4 M NE 02/17/2025 VARCEL
VARCEL
 MERCK & CO. INC.
MERCK & CO. INC.
 Y010374
Y010374
Abdominal pain, Cough, Fatigue, Influenza virus test negative, Painful respirati... Abdominal pain, Cough, Fatigue, Influenza virus test negative, Painful respiration; Pyrexia, SARS-CoV-2 test negative, Streptococcus test negative More
Cough started next day, fever on January 20th with fatigue, "breath hurts", abdominal pain... Cough started next day, fever on January 20th with fatigue, "breath hurts", abdominal pain. No sore throat or runny nose More
2826565 4 F NC 02/17/2025 MMRV
 MERCK & CO. INC.
 X027626
Injection site erythema, Injection site pain, Injection site swelling, Pyrexia Injection site erythema, Injection site pain, Injection site swelling, Pyrexia
within 24 hrs patient had moderate sized red and swollen reaction at site of injection with pain, mi... within 24 hrs patient had moderate sized red and swollen reaction at site of injection with pain, minor fever that took 3 days for redness and 5 days for swelling to resolve More
2826566 9 F MA 02/17/2025 COVID19
COVID19
FLU3
FLU3
COVID19
COVID19
FLU3
FLU3
 PFIZER\BIONTECH
PFIZER\BIONTECH
GLAXOSMITHKLINE BIOLOGICALS
GLAXOSMITHKLINE BIOLOGICALS
PFIZER\BIONTECH
PFIZER\BIONTECH
GLAXOSMITHKLINE BIOLOGICALS
GLAXOSMITHKLINE BIOLOGICALS
 lm2045
lm2045
n7cx5
n7cx5
LM2045
LM2045
n7cx5
n7cx5
Crying, Nausea, Vomiting; Crying, Nausea, Syncope, Vomiting; Crying, Nausea, Vom... Crying, Nausea, Vomiting; Crying, Nausea, Syncope, Vomiting; Crying, Nausea, Vomiting; Crying, Nausea, Syncope, Vomiting; Crying, Nausea, Vomiting; Crying, Nausea, Syncope, Vomiting; Crying, Nausea, Vomiting; Crying, Nausea, Syncope, Vomiting More
Patient experienced nausea and vomiting after receiving vaccination and seeing her sister experience... Patient experienced nausea and vomiting after receiving vaccination and seeing her sister experience vasovagal syncope. Patient was visibly nervous and upset at the sight of her sister's fainting spell. Patient began crying and vomiting after vaccinations. Parent reported this is the first time she has experienced this side effect. Patient was given water and monitored in the pharmacy 20-25 minutes with her sister and parents. Parents denied emergency services. Patient recovered after some time of monitoring in the pharmacy. patient left alert and feeling back to normal. Parents were told to follow up with primary care doctor and to seek emergency services if their condition worsens. More
2826567 82 F NY 02/17/2025 COVID19
COVID19
COVID19
 MODERNA
MODERNA
MODERNA
 8080750
8080750
8080750
Acute myeloid leukaemia, Biopsy bone marrow abnormal, Blood test, Chemotherapy, ... Acute myeloid leukaemia, Biopsy bone marrow abnormal, Blood test, Chemotherapy, Death; Gait inability, Imaging procedure, Laboratory test abnormal, Magnetic resonance imaging, Mobility decreased; Painful respiration, Pneumonia, SARS-CoV-2 test negative, White blood cell count increased More
Patient?s last month history. Week of 10/23/24 - Patient started having pain with breathing. (Begin... Patient?s last month history. Week of 10/23/24 - Patient started having pain with breathing. (Beginning of Phemounia - dx. 11/14/24) By 11/5 Patient could not walk due to intense pain. Monday 11/11/24 in excruciating pain, felt like she was ?going to die? - her words - could barely move. Went to orthopedic doctor thinking it was related to an old pelvic injury. She told of breathing pain for the first time. Also told of her recent COVID Vaccine of 10/5/24 at 4 pm (Spikevax, Covid19, Moderna, Lot # 8080750 Intramuscular, Left arm, dose 1), and the INFLUENZA Vaccine ( FluVax, Fluad, Seqirus, lot # 388476 Intra muscular, right arm, one dose) received 10/23/2024 at 5 pm. Patient Tested negative for Covid on 11/11/24 Tuesday 11/12/24 took Patient to primary Dr. (Dr office, saw Physicians assist.) Extremely low blood pressure, admitted to E.R. at Hospital. Blood test showed severely high white blood cell count. Leukemia mentioned for the first time. Transferred to Cancer Center, received by midnight on 11/13/24. Saw Dr, Chief of the Leukemia Service (and - Nurse Practitioner) 11/14/24 - Patient tested negative again for Covid, but TESTED POSITIVE for Acute Myeloid Leukemia (AML) and also Pneumonia. Bone marrow biopsy. Incomplete but enough info to diagnose Started oral chemo .. but white blood count doubled overnight. Received Imminent death diagnosis. Patient refused further treatment. Kept on sedatives (Dilaudid) until she died. Passed away 11/21/24 around 3 AM. (one week after diagnosis) More
โœ“ โœ“ โœ“ โœ“
2826568 12 F WA 02/17/2025 HPV9
HPV9
HPV9
HPV9
HPV9
HPV9
HPV9
HPV9
HPV9
HPV9
 MERCK & CO. INC.
MERCK & CO. INC.
MERCK & CO. INC.
MERCK & CO. INC.
MERCK & CO. INC.
MERCK & CO. INC.
MERCK & CO. INC.
MERCK & CO. INC.
MERCK & CO. INC.
MERCK & CO. INC.
 Y005835
Y005835
Y005835
Y005835
Y005835
Y005835
Y005835
Y005835
Y005835
Y005835
Alanine aminotransferase normal, Anion gap normal, Aspartate aminotransferase no... Alanine aminotransferase normal, Anion gap normal, Aspartate aminotransferase normal, Basophil count decreased, Basophil percentage; Blepharospasm, Blood albumin normal, Blood alkaline phosphatase normal, Blood bilirubin normal, Blood calcium normal; Blood chloride normal, Blood creatinine normal, Blood glucose normal, Blood potassium normal, Blood sodium normal; Blood urea decreased, Computerised tomogram head normal, Dysarthria, Eosinophil count normal, Eosinophil percentage increased; Facial paralysis, Fatigue, Globulin, Haematocrit normal, Haemoglobin normal; Hyporesponsive to stimuli, Immature granulocyte count, Loss of consciousness, Lymphocyte count normal, Lymphocyte percentage increased; Mean cell haemoglobin concentration normal, Mean cell haemoglobin normal, Mean cell volume abnormal, Mean platelet volume normal, Monocyte count normal; Monocyte percentage increased, Neutrophil count decreased, Neutrophil percentage decreased, Nystagmus, Platelet count increased; Posture abnormal, Protein total normal, Red blood cell count normal, Red blood cell nucleated morphology, Red cell distribution width normal; Tongue movement disturbance, White blood cell count normal More
Patient is here for her well-child check. She was given her HPV vaccine at the start of the visit a... Patient is here for her well-child check. She was given her HPV vaccine at the start of the visit approx. 8:56 am. She was sitting on the bench next her mom said I feel tired, slumped to the right and had brief loss of consciousness. She came to and we transferred her up onto the exam room table. An urgent response was called. We reentered the room mom noticed that her eyes were fluttering, she is holding her head turned to the right. She was minimally responsive, but able to identify where she is at and answer simple questions. Her speech is quite dysarthric. She seemed to have a slight droop of her right face, and tongue deviates to the right when protruded. Pupils are equal round reactive to light, but she has a lagging gaze with some horizontal nystagmus. Initially when she smiled there was drooping on the right but that has subsequently resolved. She continues to hold her head turned to the right. Decision was made to activate EMS for transport to the hospital. On their arrival, she still had dysarthric speech but was starting to joke and asked to go to school. She was able to stand and transfer to the stretcher with some support, though still seems weak. Continues to have a slight rightward head tilt, but has a symmetric smile now. We are approximately 40 minutes out from vaccine administration. More
2826570 30 M MN 02/17/2025 COVID19
 PFIZER\BIONTECH
Anger, Hypoaesthesia, Injection site pustule, Mobility decreased, Sepsis Anger, Hypoaesthesia, Injection site pustule, Mobility decreased, Sepsis
Bloody puss pockets at injection site that turned septic within days. Loss of feeling in both my bi... Bloody puss pockets at injection site that turned septic within days. Loss of feeling in both my bicep and triceps. I still struggle to lift my arm. Extreme rage that lasted for several weeks. More
โœ“
2826571 66 F WI 02/17/2025 COVID19
PNC21
 PFIZER\BIONTECH
MERCK & CO. INC.
 LM7786
Y013009
Hypoaesthesia, Hypoaesthesia oral; Hypoaesthesia, Hypoaesthesia oral Hypoaesthesia, Hypoaesthesia oral; Hypoaesthesia, Hypoaesthesia oral
Patient reports left side facial and lip numbness starting the morning following vaccines. She repor... Patient reports left side facial and lip numbness starting the morning following vaccines. She reports still having some numbness today 2/17/25 after receiving vaccines 1/30/25. More
2826572 8 F AR 02/17/2025 DTAPIPV
HEPA
MMRV
 GLAXOSMITHKLINE BIOLOGICALS
GLAXOSMITHKLINE BIOLOGICALS
MERCK & CO. INC.
 42Y93
DN273
X021759
No adverse event; No adverse event; No adverse event No adverse event; No adverse event; No adverse event
There were no adverse reactions There were no adverse reactions
2826574 40 F CA 02/17/2025 COVID19
COVID19
COVID19
 MODERNA
PFIZER\BIONTECH
PFIZER\BIONTECH


Menstruation irregular; Menstruation irregular; Menstruation irregular Menstruation irregular; Menstruation irregular; Menstruation irregular
Irregular menstrual cycles. Irregular menstrual cycles.
2826575 1.33 M NJ 02/17/2025 DTAP
FLU3
HEPA
 GLAXOSMITHKLINE BIOLOGICALS
GLAXOSMITHKLINE BIOLOGICALS
GLAXOSMITHKLINE BIOLOGICALS
 9PT2F
4LM54
T5727
Urticaria; Urticaria; Urticaria Urticaria; Urticaria; Urticaria
Parent stated that pt developed hives to left thigh and left side of face hours after he received va... Parent stated that pt developed hives to left thigh and left side of face hours after he received vaccines. She took him to Emergency Department on 1/16/24 at 6pm More
2826576 0.75 M NC 02/17/2025 DTAPHEPBIP
HIBV
PNC20
 GLAXOSMITHKLINE BIOLOGICALS
GLAXOSMITHKLINE BIOLOGICALS
PFIZER\WYETH
 D252F
437EK
Crying, High-pitched crying, Infant irritability, Infantile back arching, Scream... Crying, High-pitched crying, Infant irritability, Infantile back arching, Screaming; Crying, High-pitched crying, Infant irritability, Infantile back arching, Screaming; Crying, High-pitched crying, Infant irritability, Infantile back arching, Screaming More
Patient had multiple nights of severe high pitched screaming/crying, fussiness, arching of back, inc... Patient had multiple nights of severe high pitched screaming/crying, fussiness, arching of back, inconsolability, with signs and symptoms of encephalitis. More
2826577 18 M MI 02/17/2025 HEP
 GLAXOSMITHKLINE BIOLOGICALS
 Y5X9T
No adverse event No adverse event
No adverse events noted No adverse events noted
2826578 13 F CA 02/17/2025 HPV9
HPV9
HPV9
 MERCK & CO. INC.
MERCK & CO. INC.
MERCK & CO. INC.
 Gardasil
Joint swelling, Pyrexia, Rash, Rash erythematous; Joint swelling, Pyrexia, Rash,... Joint swelling, Pyrexia, Rash, Rash erythematous; Joint swelling, Pyrexia, Rash, Rash erythematous; Joint swelling, Pyrexia, Rash, Rash erythematous More
Salmon colored rash all over her body that moved around, high fever. Salmon colored rash all over her body that moved around, high fever.
โœ“
๐Ÿ“‹ Privacy Policy & Data Disclaimer